project id: TCGA-TGCT; case submitter id: TCGA-XY-A9T9; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.05; rna integrity number: 9.6; age at index: 37; days to birth: -13604; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1976; age at diagnosis: 13604; ajcc clinical m: M0; ajcc clinical n: NX; ajcc clinical stage: Stage IS; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IS; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 281.0; icd 10 code: C62.9; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 43; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-XY-A9T9-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 8.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 3.0; percent tumor cells: 89.0; percent tumor nuclei: 94.0;